Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 25, 1998

View Archived Issues

Lilly To Pay Xenova $35M For Heart Attack Drug

Gene Found That Keeps Female Embryos Female

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Canadian Biotech Groups Merge To Form National Body

Appligène Oncor Reports Disappointing '97 Results

Foiled By Nonviral Vectors, Therexsys Shifts Gene Therapy

Cerep's IPO On Nouveau Marché Raises FFr67.5M

Germany Backs China's Biotech International Exhibition

EU Advisory Panel On Ethics Formed With Lenoir As Chairman

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

HIV Drug Developer Frustrated; Pursuing Studies In China

Peptech Making Changes; Returning To Australia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...